BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2004
View Archived Issues
Novel anti-H. pylori agents designed by Kotobuki scientists
Read More
ARS presents new prostaglandin FP receptor antagonists and their use
Read More
New lipid A analogues with immunosuppressant activity discovered at Sankyo
Read More
Pirfenidone effective against cirrhosis in vivo
Read More
Phase I study for SPRC-AB01
Read More
ConjuChem updates progress of DAC:GLP-1 development
Read More
OGX-011 reduces expression of a protein that promotes cell survival in prostate cancer
Read More
Nippon Shinyaku grants Ivax license to HMN-214
Read More
Good safety profile of the Taxus Express2 stent in clinical trials and postmarketing registries
Read More
Mallinckrodt claims radiolabeled D-amino acids for cancer diagnosis and therapy
Read More
Two novel series of HDAC inhibitors patented by Fujisawa
Read More
Enanta scientists present two new series of erythromycin-based antibiotics
Read More
Roche scientists describe new selective GlyT-1 inhibitors
Read More
FDA extends review period for MS-325
Read More
ZymoGenetics licenses rFactor XIII to Novo Nordisk
Read More
Squalamine granted fast track status for wet AMD
Read More
Phase I study for Hematide
Read More
Santarus launches Zegerid
Read More
Triton BioSystems licenses ING-1 antibody from Xoma
Read More
Stellar Biotechnologies awarded NCI grant for KLH development
Read More
OraDisc A approved for aphthous ulcers
Read More
Neupro submitted for approval in U.S., Europe for Parkinson's disease
Read More
Fast track designation for MDX-010 in metastatic melanoma
Read More
Antiinflammatory agent by Uriach promising for the treatment of IBD
Read More
The inhibition of ADAM metalloproteases may present a novel approach for treatment of cancer
Read More
Targeting skeletal metastases in prostate cancer
Read More
Regulation of tumor angiogenesis and cell survival by integrin-linked kinase
Read More
Germany marks first European launch of Raptiva
Read More
Infliximab reported to reduce pain associated with Crohn's disease
Read More
Degarelix reduces testosterone and PSA levels in prostate cancer patients
Read More
Sildenafil and antidepressants improve premature ejaculation
Read More
Therapeutic effects and quality of life improvements of darifenacin in overactive bladder patients
Read More